Wells Fargo & Company Issues Pessimistic Forecast for Kimberly-Clark (NASDAQ:KMB) Stock Price

Kimberly-Clark (NASDAQ:KMB) had its price objective dropped by analysts at Wells Fargo & Company from $129.00 to $110.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside of 9.73% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. Evercore ISI reaffirmed an “in-line” rating and set a $120.00 target price (down previously from $150.00) on shares of Kimberly-Clark in a research note on Tuesday. Barclays set a $132.00 price objective on Kimberly-Clark in a report on Monday. Cowen reissued a “hold” rating on shares of Kimberly-Clark in a report on Tuesday. JPMorgan Chase & Co. increased their price objective on Kimberly-Clark from $127.00 to $129.00 and gave the company a “neutral” rating in a report on Friday. Finally, UBS Group increased their price objective on Kimberly-Clark from $130.00 to $132.00 and gave the company a “neutral” rating in a report on Friday. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $130.33.

Kimberly-Clark Stock Performance

Shares of KMB stock traded down $2.03 on Tuesday, hitting $100.24. 4,290,066 shares of the stock traded hands, compared to its average volume of 2,521,673. The company has a market capitalization of $33.26 billion, a PE ratio of 13.81, a PEG ratio of 3.67 and a beta of 0.30. The company’s fifty day moving average is $123.35 and its 200 day moving average is $129.63. The company has a debt-to-equity ratio of 4.61, a current ratio of 0.77 and a quick ratio of 0.56. Kimberly-Clark has a 1-year low of $100.24 and a 1-year high of $150.45.

Kimberly-Clark (NASDAQ:KMB) last issued its quarterly earnings data on Thursday, October 30th. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.37. The firm had revenue of $4.15 billion during the quarter, compared to the consensus estimate of $4.14 billion. Kimberly-Clark had a return on equity of 184.87% and a net margin of 12.87%.The firm’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business earned $1.83 EPS. On average, equities research analysts predict that Kimberly-Clark will post 7.5 earnings per share for the current fiscal year.

Institutional Trading of Kimberly-Clark

Several institutional investors have recently modified their holdings of KMB. Vanguard Group Inc. boosted its stake in Kimberly-Clark by 14.8% in the 2nd quarter. Vanguard Group Inc. now owns 40,435,476 shares of the company’s stock valued at $5,212,942,000 after buying an additional 5,200,011 shares in the last quarter. Norges Bank acquired a new stake in Kimberly-Clark in the 2nd quarter valued at $556,114,000. Pacer Advisors Inc. boosted its stake in Kimberly-Clark by 2,982.8% in the 1st quarter. Pacer Advisors Inc. now owns 1,384,318 shares of the company’s stock valued at $196,878,000 after buying an additional 1,339,413 shares in the last quarter. Federated Hermes Inc. boosted its stake in Kimberly-Clark by 350.2% in the 2nd quarter. Federated Hermes Inc. now owns 1,583,193 shares of the company’s stock valued at $204,105,000 after buying an additional 1,231,501 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its stake in Kimberly-Clark by 32,568.4% in the 2nd quarter. Balyasny Asset Management L.P. now owns 978,419 shares of the company’s stock valued at $126,138,000 after buying an additional 975,424 shares in the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.